Phase I study of alphaviral vector (AVX701) in colorectal cancer patients: comparison of immune responses in stage III and stage IV patients

समान संसाधन

• Novel Recombinant Alphaviral and Adenoviral Vectors for Cancer Immunotherapy
  द्वारा: Osada, Takuya, और अन्य
  प्रकाशित: (2012)
• Long-term survival of patients with stage III colon cancer treated with VRP-CEA(6D), an alphavirus vector that increases the CD8+ effector memory T cell to Treg ratio
  द्वारा: Crosby, Erika J, और अन्य
  प्रकाशित: (2020)
• Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines
  द्वारा: Morse, Michael A., और अन्य
  प्रकाशित: (2008)
• An alphavirus vector overcomes the presence of neutralizing antibodies and elevated numbers of Tregs to induce immune responses in humans with advanced cancer
  द्वारा: Morse, Michael A., और अन्य
  प्रकाशित: (2010)
• Optimization of vaccine responses with an E1, E2b, E3 deleted Ad5 vector circumvents pre-existing anti-vector immunity
  द्वारा: Osada, Takuya, और अन्य
  प्रकाशित: (2009)